| |
|
|
|
|
|
|
|||
|
Prepublished online as a Blood First Edition Paper on April 30, 2002; DOI 10.1182/blood-2001-12-0191.
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
From INSERM U 474, Institut Cochin, Paris, France, and
Faculté de Médecine Paris-Ile de France-Ouest, France.
Platelets can bind and phagocytose infectious microorganisms and so
enable their transport for a prolonged time. To investigate the
subcellular events of these interactions, platelets were incubated either with Staphylococcus aureus or with HIV and analyzed
by electron microscopy (EM) and immuno-EM. HIV and bacteria
internalization occurred exclusively within platelets showing
morphological evidence of activation. Platelet activation enhanced the
degree of bacterial internalization. Immunolabeling revealed that the
engulfing vacuoles and the open canalicular system (OCS) were composed
of distinct antigens. The engulfing vacuoles eventually became the site
of prominent Although the critical role of blood platelets in
hemostasis and thrombosis is clearly recognized, their capacity to
function during host defense against infection has received much less
attention. Thrombocytopenia is often a severe complication during or
after bacterial and viral infections. The mechanisms responsible appear to be multiple: increased platelet destruction, due either to the
nonspecific deposition of circulating immune complexes on platelets or
to the presence of specific antiplatelet antibodies, and decreased
platelet production.1,2 More specifically, several studies
have indicated that during infection with HIV, there is a
direct interaction of HIV with megakaryocytes and platelets: mature
megakaryocytic cells express CD4 along with HIV coreceptors CXCR1, 2, and 4 and CCR3 and 5 on their surface3-6 and are
thus susceptible to HIV infection; productive infection of
megakaryocytes by X4 and R5 HIV-1 isolates has also been
shown7; and megakaryocytes from seropositive subjects have
been found to contain viral RNA and antigens by in situ
hybridization.3,8 These are arguments for decreased
platelet production. HIV-1 RNA has also been detected in platelet
preparations by reverse-transcriptase-polymerase chain reaction, and platelets that are washed, but depleted of
leukocytes, appear to retain high concentration of tightly
associated HIV messenger RNA.9 A direct interaction
between platelets and HIV has also been shown.10 Moreover,
platelets also express the HIV coreceptors (CXCR1, 2, and 4 and CCR 1, 3, and 4) on their surface.4,11
It is also conceivable that during bacterial infection, direct
interaction between platelets and bacteria may contribute to the
observed thrombocytopenia. Several studies performed in vitro on the
interaction of platelets with Staphylococcus aureus
indicated that the bacteria induce the platelet-release reaction and
rapid irreversible platelet aggregation in the presence of normal
plasma; in these experiments, internalization of S aureus by
individual platelets occasionally occurred.12-15 It has
also been shown that Therefore, the aim of this study was to use electron microscopy (EM)
and immuno-EM to fully elucidate the mechanism of direct platelet-microorganism interactions, in particular those associated with S aureus and HIV internalization by platelets.
We also examined the potential role of platelet activation on the
ability of platelets to internalize infectious microorganisms
and documented the subcellular distribution of platelet antigens during
the interaction of platelets with bacteria. The interaction of
platelets with HIV was also investigated with specific immunogold
labeling of internalized HIV, either in vitro or in vivo, within
platelets of patients with AIDS and thrombocytopenia.
Cells
Platelets of a patient with AIDS, high plasma viremia, and
thrombocytopenia were obtained by venipuncture into plastic tubes containing ACD-C, fixed in whole blood in 1.5% glutaraldehyde for 1 hour, and washed 3 times in 0.1 M phosphate buffer, pH 7.4.
Bacteria
Platelet-bacteria interaction Washed platelets (2 × 109/mL) were incubated with S aureus suspension with an excess of bacteria (1010/mL) at 37°C for 1 hour. The effect of platelet activation was also studied by preactivating the platelets with 10 µM adenosine 5'-diphosphate (ADP) for 30 minutes or 0.1 U/mL thrombin for 5 minutes, with appropriate controls. Cells were then fixed by the addition of glutaraldehyde up to a final concentration of 1% in 0.1 M phosphate buffer.Human immunodeficiency virus The HIV-1 particles were obtained from the supernatant of peripheral blood mononuclear cell (PBMC) culture of HIV-1-infected patients by centrifugation at 25 000g for 15 minutes and were resuspended in HBSS.Platelet-HIV interaction Washed platelets (2 × 109/mL) were directly incubated with a viral pellet with reverse-transcriptase activity of approximately 10 000 cpm.Antibodies A pool of 3 monoclonal antibodies against the core protein p24 HIV-1 was a generous gift from Dr H. R. Gelderblom (Berlin, Germany).18 Antihuman polyclonal rabbit antibodies anti- IIb 3,19 antiglycocalicin (anti-glycoprotein Ib
[anti-GPIb]),20 and anti-P-selectin (CD62p)21 were kindly provided by Dr Michael Berndt
(Prahran, Victoria, Australia). Antifibrinogen22
was purchased from Dako (Glostrup, Denmark). These antibodies were used
at 10 µg/mL. Goat anti-rabbit and goat anti-mouse immunoglobulin-G
fractions coupled to 10 nm gold particles (GAR-G10, GAM-G10) were
purchased from British Biocell International (Cardiff, United Kingdom)
and used at 1/30 dilution.
Electron microscopy Samples were fixed in 1.5% glutaraldehyde for 1 hour and washed 3 times in 0.1 M phosphate buffer, pH 7.4. For morphologic examination, fixed platelets were postfixed in 1% osmic acid, dehydrated in ethanol, and embedded in Epon by standard methods.Immunolabeling For immunolabeling experiments, fixed platelets were embedded in sucrose (for cryosections)23 or glycolmethacrylate (for ultrathin sections), and the immunochemical reactions were performed on thin sections collected on nickel grids.24 Briefly, we labeled sections first by incubating them with the primary antibodies for 2 hours at 22°C in a humidified atmosphere and then washing them thoroughly in Tris-buffered saline. This was followed by incubation with GAR-G10 or GAM-G10 for 1 hour at 22°C. Samples were counterstained and were observed on a Philips CM 10 electron microscope (Eindhoven, The Netherlands).
Platelet and bacteria interaction Activated platelets are able to internalize bacteria (S aureus). The ultrastructural examination of washed platelets incubated with S aureus demonstrated that the internalization of bacteria within platelets was rare. Nevertheless, in the few platelets where bacteria internalization appeared to have occurred, the platelets presented morphological signs of activation with characteristic spherical shape, bristled surface with a few pseudopods, dilation of the open canalicular system (OCS), and rare cytoplasmic granules. Platelet activation increases bacteria internalization.
To elucidate whether platelet activation preceded and facilitated
bacteria internalization or whether bacteria uptake induced platelet
activation, washed platelets were activated by ADP or thrombin and
incubated with bacteria. Examination of platelet samples incubated with
S aureus in the absence of an exogenous platelet activator
demonstrated that platelets remained discoid and apparently
inactivated, and bacteria were retrieved in the vicinity of platelets
without being internalized (Figure 1A). In contrast, agonist-activated platelets exhibited frequent images of
bacteria internalization (Figure 1B). This observation led to the
conclusion that platelet activation considerably increases bacteria
internalization.
Bacteria engulfment occurs in a specific subcellular compartment.
To document the antigenic composition of the limiting membrane of
vacuoles that surround internalized bacteria (engulfing vacuoles),
immunolabeling experiments were performed on thin sections of
thrombin-activated platelets incubated with S aureus, by
using antibodies against several platelet glycoproteins
(
In these samples, some platelets appeared to extend pseudopods that wrapped around the bacteria. The platelet pseudopods surrounded the particle by the process of circumferential adherence until they fully enclosed the particle in a vacuole consisting of internalized extracellular space surrounded by plasma membrane, in a manner that closely resembles phagocytes engulfing bacteria. This observation suggests that an active process leads to bacteria internalization (Figure 3A) and that passive, amorphous passage of bacteria into the OCS is unlikely.
Finally, in platelets with 1 or 2 large vacuoles containing bacteria, immunolabeling for fibrinogen provided evidence that secretion of the granule contents also occurs around internalized bacteria. Also apparent were some images demonstrating fusion of -granules
either among themselves or with the endocytic vacuole (Figure 3B-C).
Finally, fusion of the engulfing vacuoles with the OCS-containing
fibrinogen also occurred (not shown). These observations indicate that,
at the final step of internalization, bacteria appear to be in contact
with granule secretory products.
Platelets and HIV interaction HIV internalization by platelets occurs in endosomelike structures.
The ultrastructural examination of washed platelets incubated with the
supernatant of HIV-infected cultured cells showed typical images of
virus internalization. In the early stage of internalization, HIV
particles were found in small vacuoles tightly surrounding 1, 2, or 3 particles, were located close to the plasma membrane (Figure
4A), and resembled endosomal structures.
Virus particles were also found in the dilated channels of OCS,
possibly following their fusion with the engulfing vacuoles (Figure
4B-C). This process resembled what had been observed with
bacteria.
HIV internalization occurs preferentially in activated platelets. Interestingly, viral particles were observed exclusively in platelets undergoing secretion and displaying morphological activation signs: uneven surface, extension of pseudopods, degranulation, and dilated OCS (Figure 4A-C). Specific uptake of HIV by platelets.
HIV identification was also performed by immunogold labeling on
ultrathin cryosections of platelets incubated with HIV particles, with
the use of a pool of 3 monoclonal antibodies directed against the core
protein p24. This technique was sensitive enough to specifically detect
a single viral particle within the whole platelet cytoplasmic area
(Figure 5A) without any unspecific
labeling.
This technique was also performed on the supernatant of infected PBMCs used for platelet incubation. It showed that the proportion of viral particles in the culture supernatant was quite low in terms of cellular debris (Figure 5B). This tends to demonstrate that platelets selectively take up HIV particles, preferentially to cellular debris. Ultrastructural aspect of platelet-HIV interaction in vivo.
An ultrastructural study of isolated platelets from a patient with
AIDS, high viremia level, and thrombocytopenia was performed. In this
sample, we observed a viral particle tightly enclosed within a small,
typical endocytic vacuole (Figure 6). The
particle exhibited the size, shape, and dense core characteristic of
HIV. The results obtained in vivo tend to confirm the in vitro data and
indicate that HIV endocytosis into platelets may occur during HIV
infection.
The mechanism by which platelets interact with infectious microorganisms is poorly understood. In this study, we have focused on the interaction of washed normal platelets with either bacteria (S aureus) or viral particles (HIV). The susceptibility of bacteria internalization was initially studied under conditions that prevent platelet aggregation (washed platelets and washed bacteria). Although engulfment of bacteria by resting platelets was rare, the few platelets in which internalization was evident displayed the characteristics of platelet activation. However, under these experimental conditions, no major platelet activation was induced by the bacteria. To determine whether platelet activation triggered or enhanced bacterial uptake, platelet agonists were added in the incubation medium. These experiments showed that platelet activation greatly increases bacteria internalization. The first step of phagocytosis is bacterial adherence to the cell
surface, which usually requires the participation of a receptor and a
ligand. Recently, it has been shown that the receptor for the
complement component C1q (C1qR/p33) is recognized by S
aureus protein26; this indicates that C1qR could be a
potential binding site for S aureus. It is noteworthy that
C1qR/p33 is expressed on platelet surface after platelet
activation.27 In addition, thrombospondin, which has been
described as an S aureus-adherence mediator, is also
secreted from the To elucidate the mechanisms of S aureus interaction with
platelets, we proceeded to study the subcellular distribution of receptors in platelets engulfing bacteria. Immunolabeling experiments for Examination of the antigenic composition of the engulfing vacuoles
suggested that they express a distinct composition from the OCS since
GPIb, which is present in OCS, was not detected within the engulfing
vacuoles. In fact, the antigenic composition of the engulfing vacuoles
is the same as the plasma membrane after activation (expression of
In platelets with large vacuoles containing bacteria, fibrinogen
labeling suggests that Examination of platelets incubated with the supernatant of HIV-infected PBMC culture shows intracellular HIV particles with their characteristic size, shape, and eccentric dense core.31 At the early step of internalization, HIV particles were tightly surrounded by endosomelike structures and located close to the plasma membrane. These images are very similar to those associated with HIV transcytosis in epithelial cells. Transcytosis is a mechanism that involves translocation of HIV particles through epithelial cells by endocytosis without infecting the epithelium itself.32,33 Transcytosis in platelets differs from epithelial cells because platelets are isolated, secretory cells. In addition, endosomelike structures containing HIV particles in platelets would be expected to fuse with the OCS as observed. Remarkably, platelets that contained intracellular viruses also displayed activation signs. Granular components would then also be secreted on HIV particles, in a manner similar to the process that occurs in bacteria internalization by platelets. Immuno-EM using a pool of monoclonal antibodies against the core protein p24 was demonstrated to be a specific and sensitive technique since we could detect a single viral particle in the whole platelet surface. It also showed that HIV particles were rare in the supernatant of infected platelets, suggesting that the cells could selectively internalize HIV virions preferentially over cellular debris. Finally, examination of HIV viremia in various plasma samples more or less contaminated with platelets showed an increase of HIV RNA copy number per unit of plasma volume parallel to the intensity of platelet contamination. Finally, examination of platelets of a patient with AIDS allowed us to validate the results we obtained in vitro. Our observations suggest that this phenomenon can occur in HIV-infected patients and may therefore be a cause of platelet destruction and thrombocytopenia. In analogy with the phagocytic process, engulfing vacuoles can be
compared to phagosomes, and the fusion of these vacuoles with granules
can be compared to the phagosome-lysosome fusion, which
permits the release of granular materials onto the microorganisms. The
granular components exhibit microbicidal and antiviral activity. Indeed, previous studies have shown the existence of 2 microbicidal proteins from human blood platelets called thrombocidins34
and have shown that platelets are a source of RANTES (regulate upon activation normal T-cell-expressed and secreted)
chemokines,35-37 which have been known for their
suppressive effects on HIV infection,38 even before the
discovery of HIV CCR5 coreceptor. These proteins, stored in the
An alternative hypothesis would be that endocytosis of HIV by platelets would be a pathway that HIV could use to evade either the immune system or anti-HIV treatment. Therefore, further studies need to be performed to elucidate the incidence of platelet/microorganism interaction and its effect on the general capacity of the human host to defend against infection. In conclusion, our results demonstrate that (1) platelet activation greatly facilitates microorganism uptake; (2) internalization occurs in endosomelike structures that are different from the OCS, in a probably selective and active manner; and (3) platelets may play an essential role in host defense.
Submitted December 6, 2001; accepted February 1, 2002.
Prepublished online as Blood First Edition Paper, April 30, 2002; DOI 10.1182/blood-2001-12-0191.
Supported by a fellowship from L'Association Nationale pour la Recherche contre le SIDA (T.Y.).
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Elisabeth Cramer, INSERM U 474, Maternité 5ème étage, Hôpital de Port-Royal, 123 Boulevard Port-Royal, 75014, Paris, France; e-mail: elisabeth.cramer{at}cochin.inserm.fr.
1.
Dominguez A, Gamallo G, Garcia R, Lopez- Pastor A, Pena JM, Vazquez JJ.
Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients.
J Clin Pathol.
1994;47:999-1003
2.
Bettaieb A, Fromont P, Louache F, et al.
Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura.
Blood.
1992;80:162-169 3. Louache F, Vainchenker W. Thrombocytopenia in HIV infection. Curr Opin Hematol. 1994;1:369-372[Medline] [Order article via Infotrieve].
4.
Kouri YH, Borkowsky W, Nardi M, Karpatkin S, Basch RS.
Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1.
Blood.
1993;81:2664-2670
5.
Riviere C, Subra F, Cohen-Solal K, et al.
Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesis.
Blood.
1999;93:1511-1523
6.
Lee B, Ratajczak J, Doms RW, Gewirtz AM, Ratajczak MZ.
Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection.
Blood.
1999;93:1145-1156 7. Voulgaropoulou F, Pontow SE, Ratner L. Productive infection of CD34+-cell-derived megakaryocytes by X4 and R5 HIV-1 isolates. Virology. 2000;269:78-85[CrossRef][Medline] [Order article via Infotrieve].
8.
Zucker-Franklin D, Cao YZ.
Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA.
Proc Natl Acad Sci U S A.
1989;86:5595-5599 9. Lee TH, Stromberg RR, Heitman JW, Sawyer L, Hanson CV, Busch MP. Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with platelets. Transfusion. 1998;38:580-588[CrossRef][Medline] [Order article via Infotrieve].
10.
Zucker-Franklin D, Seremetis S, Zheng ZY.
Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets.
Blood.
1990;75:1920-1923
11.
Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini, Wells TN.
Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets.
Blood.
2000;96:4046-4054 12. Clawson CC. Platelet interaction with bacteria, 3: ultrastructure. Am J Pathol. 1973;70:449-471[Medline] [Order article via Infotrieve]. 13. Clawson CC, Rao GH, White JG. Platelet interaction with bacteria, IV: stimulation of the release reaction. Am J Pathol. 1975;81:411-420[Abstract]. 14. Clawson CC, White JG. Platelet interaction with bacteria, V: ultrastructure of congenital afibrinogenemic platelets. Am J Pathol. 1980;98:197-211[Abstract]. 15. Clawson CC, White JG, Herzberg MC. Platelet interaction with bacteria, VI: contrasting the role of fibrinogen and fibronectin. Am J Hematol. 1980;9:43-53[Medline] [Order article via Infotrieve].
16.
Bhakdi S, Muhly M, Mannhardt U, et al.
Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets.
J Exp Med.
1988;168:527-542
17.
Arvand M, Bhakdi S, Dahlback B, Preissner KT.
Staphylococcus aureus alpha-toxin attack on human platelets promotes assembly of the prothrombinase complex.
J Biol Chem.
1990;265:14377-14381 18. Gelderblom HR, Hausmann EH, Ozel M, Pauli G, Koch MA. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology. 1987;156:171-176[CrossRef][Medline] [Order article via Infotrieve].
19.
Cramer EM, Savidge GF, Vainchenker W, et al.
Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes.
Blood.
1990;75:1220-1227
20.
Berger G, Masse JM, Cramer EM.
Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V.
Blood.
1996;87:1385-1395
21.
Youssefian T, Masse JM, Rendu F, Guichard J, Cramer EM.
Platelet and megakaryocyte dense granules contain glycoproteins Ib and IIb-IIIa.
Blood.
1997;89:4047-4057
22.
Cramer EM, Debili N, Martin JF, et al.
Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes.
Blood.
1989;73:1123-1129
23.
Youssefian T, Cramer EM.
Megakaryocyte dense granule components are sorted in multivesicular bodies.
Blood.
2000;95:4004-4007
24.
Cramer EM, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J.
Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes.
Blood.
1985;66:1309-1316 25. Cramer E, Berger G. Immunoelectron microscopic changes of the platelet plasma membrane after activation. Blood Coagul Fibrinolysis. 1996;7:172-177[Medline] [Order article via Infotrieve].
26.
Nguyen T, Ghebrehiwet B, Peerschke EI.
Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets.
Infect Immun.
2000;68:2061-2068 27. Peerschke EI, Ghebrehiwet B. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunobiology. 1998;199:239-249[Medline] [Order article via Infotrieve].
28.
Herrmann M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD.
Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces.
Infect Immun.
1991;59:279-288
29.
Hourdille P, Heilmann E, Combrie R, Winckler J, Clemetson KJ, Nurden AT.
Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets.
Blood.
1990;76:1503-1513
30.
Fox JE, Lipfert L, Clark EA, Reynolds CC, Austin CD, Brugge JS.
On the role of the platelet membrane skeleton in mediating signal transduction: association of GP IIb-IIIa, pp60c-src, pp62c-yes, and the p21ras GTPase-activating protein with the membrane skeleton.
J Biol Chem.
1993;268:25973-25984
31.
Nakai M, Goto T.
Ultrastructure and morphogenesis of human immunodeficiency virus.
J Electron Microsc (Tokyo).
1996;45:247-257 32. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med. 1997;3:42-47[CrossRef][Medline] [Order article via Infotrieve]. 33. Bomsel M, Heyman M, Hocini H, et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity. 1998;9:277-287[CrossRef][Medline] [Order article via Infotrieve].
34.
Krijgsveld J, Zaat SA, Meeldijk J, et al.
Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines.
J Biol Chem.
2000;275:20374-20381 35. Power CA, Clemetson JM, Clemetson KJ, Wells TN. Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine. 1995;7:479-482[CrossRef][Medline] [Order article via Infotrieve]. 36. Majka M, Rozmyslowicz T, Lee B, et al. Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV. J Clin Invest. 1999;104:1739-1749[Medline] [Order article via Infotrieve].
37.
Holme PA, Muller F, Solum NO, Brosstad F, Froland SS, Aukrust P.
Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection.
FASEB J.
1998;12:79-89
38.
Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P.
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.
Science.
1995;270:1811-1815 39. Brandt E, Petersen F, Ludwig A, Ehlert JE, Bock L, Flad HD. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J Leukoc Biol. 2000;67:471-478[Abstract].
40.
Evangelista V, Manarini S, Sideri R, et al.
Platelet/polymorphonuclear leukocyte interaction: P- selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule.
Blood.
1999;93:876-885
© 2002 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
D. A. Trier, K. D. Gank, D. Kupferwasser, N. Y. Yount, W. J. French, A. D. Michelson, L. I. Kupferwasser, Y. Q. Xiong, A. S. Bayer, and M. R. Yeaman Platelet Antistaphylococcal Responses Occur through P2X1 and P2Y12 Receptor-Induced Activation and Kinocidin Release Infect. Immun., December 1, 2008; 76(12): 5706 - 5713. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. von Hundelshausen and C. Weber Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease Circ. Res., January 5, 2007; 100(1): 27 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chaipan, E. J. Soilleux, P. Simpson, H. Hofmann, T. Gramberg, A. Marzi, M. Geier, E. A. Stewart, J. Eisemann, A. Steinkasserer, et al. DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by Platelets. J. Virol., September 1, 2006; 80(18): 8951 - 8960. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Rouyez, M. Lestingi, M. Charon, S. Fichelson, A. Buzyn, and I. Dusanter-Fourt IFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter Activity J. Immunol., April 1, 2005; 174(7): 3948 - 3958. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. White Platelets Are Covercytes, Not Phagocytes. Blood (ASH Annual Meeting Abstracts), November 16, 2004; 104(11): 3533 - 3533. [Abstract] |
||||
![]() |
P. Pawar, P. K. Shin, S. A. Mousa, J. M. Ross, and K. Konstantopoulos Fluid Shear Regulates the Kinetics and Receptor Specificity of Staphylococcus aureus Binding to Activated Platelets J. Immunol., July 15, 2004; 173(2): 1258 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-C. Mercier, R. M. Dietz, J. L. Mazzola, A. S. Bayer, and M. R. Yeaman Beneficial Influence of Platelets on Antibiotic Efficacy in an In Vitro Model of Staphylococcus aureus-Induced Endocarditis Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2551 - 2557. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||